Section Arrow
PEN.NYSE
- Penumbra
Quotes are at least 15-min delayed:2025/08/27 07:04 EDT
Pre Market
Last
 266.34
+0.34 (+0.13%)
Bid
106.4
Ask
298
High 266.99 
Low 265.4 
Volume 218 
Regular Hours
Last
 266
+1.83 (+0.69%)
Day High 
270 
Prev. Close
264.17 
1-M High
268.81 
Volume 
606.38K 
Bid
106.4
Ask
298
Day Low
263.225 
Open
264.73 
1-M Low
225.48 
Market Cap 
10.30B 
Currency USD 
P/E 69.89 
%Yield -- 
10-SMA 255.67 
20-SMA 248.73 
50-SMA 246.48 
52-W High 310 
52-W Low 184.8 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
3.78/4.99
Enterprise Value
10.51B
Balance Sheet
Book Value Per Share
33.18
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.19B
Operating Revenue Per Share
25.51
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.4303-0.0596-12.17%-- 
Pre Market 0.415 -0.0153 -3.56%
PTHLPheton Holdings Ltd0.6689+0.1033+18.26%-- 
Pre Market 0.65 -0.0189 -2.83%
MDTMedtronic plc92.18+0.14+0.15%25.5PE
Pre Market 92.52 +0.34 +0.37%
ABTAbbott Laboratories131.59-0.28-0.21%16.55PE
Pre Market -- -- --
BFLYButterfly Network1.59+0.04+2.58%-- 
Pre Market 1.6 +0.01 +0.63%
Quotes are at least 15-min delayed:2025/08/27 07:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.